An interventional study of Daily Activity Text and Control Text in Pulmonary Embolism, sponsored by University of Rochester. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-18.
Sponsored by University of Rochester · Not applicable, Interventional, and Supportive care
The purpose of this study is to evaluate whether a home rehabilitation program after hospitalization for acute pulmonary embolism (PE) improves clinical outcomes at 3 months compared to usual care. Daily physical activity tasks that incorporate heart rate monitoring will be sent through email or text. This information could help improve the management of acute PE.
739 studies on the registry are indexed under Pulmonary Embolism; 159 are open to participants now.
This study's enrollment of 32 is below the median of 150 across 381 interventional studies indexed under Pulmonary Embolism.
Browse Pulmonary Embolism studies →University of Rochester is the lead sponsor of 715 studies on the registry; 116 are open to participants now.
Of its 56 completed or terminated interventional studies of FDA-regulated products, 44 (79%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
The intervention group will receive instructions for a daily activity sent through SMS text message or email.
Behavioral: Daily Activity Text
The control group will receive daily messages to help with blinding sent through text message or email. The messages will not include activity tasks and will include phrases such as "I hope you have a good day".
Behavioral: Control Text
Participants will receive a text each day with instructions about the daily activity they should complete for that day.
Participants will receive a text each day with no instructions about daily activity. It will have messages like "have a nice day."
mean change in vector magnitude count as measured by actigraphy
The Actigraph triaxial accelerometer will be used to monitor continuous activity at home on the non-dominant wrist. The accelerometer data will be downloaded and will include the vector magnitude count.
Time frame: 10 weeks
mean change in mean amplitude deviation as measured by actigraphy
The Actigraph triaxial accelerometer will be used to monitor continuous activity at home on the non-dominant wrist. The accelerometer data will be downloaded and will include the mean amplitude deviation.
Time frame: 10 weeks
proportion of participants with post-PE syndrome
Participants will be evaluated by a physician to determine if they have post PE-syndrome
Time frame: 12 weeks
mean change in steps as measured by Actigraph
The Actigraph triaxial accelerometer will be used to monitor the number of steps taken at home on the non-dominant wrist. The accelerometer data will be downloaded and will include the step count.
Time frame: 12 weeks
mean change in activity as measured by Actigraph
The Actigraph triaxial accelerometer will be used to monitor the amount of activity taken at home on the non-dominant wrist. The accelerometer data will be downloaded and will include the amount of activity.
Time frame: 12 weeks
mean change in quality of life as measured by PROMIS
The PROMIS questionnaire ranges from 0-99 with higher scores indicating worse outcome.
Time frame: 12 weeks
mean change in quality of life as measured by Emphasis 10
The Emphasis 10 questionnaire ranges from 0-50 with higher scores indicating worse quality of life.
Time frame: 12 weeks
mean change in quality of life as measured by Pulmonary Embolism quality of life questionnaire
The pulmonary embolism quality of life questionnaire ranges from 1 to 27 with higher scores indicating worse outcomes.
Time frame: 12 weeks
mean change in 6 minute walking distance
Time frame: 12 weeks
mean change in heart rate during a 6 minute walk
Time frame: 12 weeks
mean change in oxygen use during a 6 minute walk
Oxygen use will be measured by a measured by portable K5 metabolic analyzer.
Time frame: 12 weeks
mean change in carbon dioxide production during a 6 minute walk
Carbon Dioxide use will be measured by a measured by portable K5 metabolic analyzer.
Time frame: 12 weeks
proportion or subjects who develop chronic thromboembolic pulmonary hypertension
Time frame: 12 weeks
Plan to share: No
This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Rochester